<DOC>
	<DOC>NCT01198717</DOC>
	<brief_summary>The aim of this study is to evaluate the progression of ET in children (aged 6-17years inclusive) over a period of 5 years maximum. The study will also assess how children are diagnosed, treatment options for those children with symptoms and events related to their ET and the outcomes of those treatments.</brief_summary>
	<brief_title>Pediatric Disease Registry in Essential Thrombocythaemia (ET)</brief_title>
	<detailed_description />
	<mesh_term>Thrombocytosis</mesh_term>
	<mesh_term>Thrombocythemia, Essential</mesh_term>
	<criteria>6 years or over and less than 18 years patient has ET according to the WHO criteria as guidance Interventional clinical study participation</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>